Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
GSK’s Dheepa Chari on the evolving sphere of scientific communication
Dheepa Chari joins EMJ GOLD to discuss her career path, AI in pharma and the future of scientific communication.
Read more
Innovation, collaboration and creativity as a contact sport
Magnus Björsne, CEO, AstraZeneca BioVentureHub, discusses the impact of the pandemic on innovation, collaboration and creativity.
Pharma in China, untapped markets and drug development
In this episode, Marc and Helena talk China with Novartis’ Isabel Afonso and drug development with Farid Khan, CEO of PharmaKure. Listen now!
Claire Skentelbery, Director General, EuropaBio
Bonus episode this week for GOLD podcast, featuring a full feature-length interview with Claire Skentelbery, Director General, EuropaBio. Stream now!
The risks, rewards and future potential of biotechnology
In this episode, Marc and Helena have a chat about biotech with special guest Claire Skentelbery, Director General of EuropaBio.
GP insights, preventative care and patient centricity
In this episode, Marc and Helena will chat with GP Nigel Guest about his thoughts about preventative medicines and his insights for pharma sales teams.
International Women’s Day special
In this special bumper episode, GOLD celebrates International Women’s Day by speaking to Nikki Jones (HBA) and Aliya Omer (Kite Pharma) about the role of women in pharma industry.
Digital health, biotech and the metaverse
New podcast episode about digital health apps and the metaverse. Guests Liz Ashall-Payne (ORCHA) and Dario Safaric (NEXT Pharma). Listen now!
Innovative tech, pharma supply chains and more
Marc and Helena chat with Wayne Best, Chief Creative Officer, VMLY&R, about his ‘I Will Always Be Me’ project for patients with motor neurone disease. Listen now!
Vaccines, leadership and blockchain
A chat with Judy Stewart (GSK) and Vincent Steine in the first episode of a new season of GOLD podcasts. Tune in to find out more about vaccines, pharma and blockchain.
Season finale: GOLD Medal Moments
Marc and Helena review the last year and reminisce about the podcast’s ‘GOLD Medal Moments’ from the past 12 months. Listen now!
Margo Warren on global access to medicine
Marc and Helena introduce Margo Warren from the Access to Medicine Foundation to discuss health equality and vaccine distribution.
The 2022 Pharma Forecast
Join Marc and Helena in kicking off the new year with an episode predicting what 2022 has in store for pharma. Listen now!
A roundtable review of 2021
To round off the year, three GOLD Podcast guests return to review 2021 in the pharmaceutical industry. Listen now!
Catherine Owen on the future of data
Catherine Owen, Head of Major Markets at Bristol Myers Squibb, discusses upcoming changes to pharma’s data policies.
Tamika Jean-Baptiste on diversity and inclusion
Tamika Jean-Baptiste, Vice President and Chief Diversity Officer, Amgen, discusses her lifelong passion for diversity.
Chumi Khurana on men’s health
Chumi Khurana, Global Head, Prostate Cancer Disease Area Stronghold, Janssen Oncology speaks about her pathway into men’s health and more.
Dr Richard Kaszynski on the importance of antivirals
Dr Richard Kaszynski, Chief Medical Officer, AiPharma, discusses the emerging role of antivirals in healthcare.
Tanja Dowe on digital health tools
Tanja Dowe, CEO, Debiopharm Innovation Fund, discusses with GOLD team her passion for digital health tools.
Dr Emma Roffe and Eric Low on combination treatments
Dr Emma Roffe, Takeda UK, and Eric Low, Myeloma UK, talk about the challenge of combination treatments.
Massimiliano Siciliano on digital potential
Massimiliano Siciliano, Digital Solution Director Europe, Novartis, talks about the potential of digital solutions for pharma stakeholders.
Clare Hague on drug pricing and market access
Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen, discusses drug pricing.
Julie Ross on International Equal Pay Day
Julie Ross, President, Advanced Clinical, talks about gender parity in the workplace in aid of International Equal Pay Day.
Carol Ross on corporate responsibility
Carol Lynch, Chief Business Officer, Sandoz, talks about how to increase the number of women in leadership positions in pharma and more.
Keren Leshem on running a women's health business
Keren Leshem, Chief Executive Officer, OCON Healthcare, discusses how she transformed the women’s health company’s business strategy.
Edmond Chan on improving patient outcomes
Edmond Chan, Senior Director, EMEA Therapeutic Area Lead, Haematology, Janssen, discusses the MA impact on improving patient outcomes.
Dr Jerome Kim on vaccines
Dr Jerome Kim, Director General, International Vaccine Institute, discusses pharma’s role in addressing vaccine hesitancy and refusal.
Talking to Dirk Kosche
Dirk Kosche, President, Established Markets, Astellas Pharma Europe, discusses turning innovation into value for patients.
Talking to Jennifer Cain Birkmose
Jennifer Cain Birkmose, Senior Pharmaceutical Leader in Market Access, Patient Access, and Patient Advocacy, discusses clinical trials.
Talking to Vanessa Pott
Vanessa Pott, Director, Global Patient Insights and Advocacy, Merck KGaA, discusses patient advocacy and supporting carers.
Talking to Alexey Cherchago
Alexey Cherchago, Head of Sales Excellence Europe, Sandoz, talks about leadership and the evolving medical sales representative role.
Talking to Denise Dewar
Denise Dewar, Digital Hub Director, Europe, Japan and Canada, GSK, discusses digital transformation and swapping whisky for pharma.
Talking to Ana Rita Ferreira
Ana Rita Ferreira, Region Europe Medical Director, Novartis, discusses cancer care, women in STEM and misinformation.
Talking to Lorena Kuri
Lorena Kuri, Director of Clinical Trial Diversity Strategy, BMS, discusses how to address underrepresentation in clinical trials.
Talking to Rodrigo Garcia
Rodrigo Garcia, Head of Patient Centricity, Recruitment and Retention, EMD Serono, discusses the importance of diverse clinical trials.
Talking to Sir Clive Woodward part 2
Sir Clive Woodward, Former England Rugby Coach, discusses the importance of teams having aligned values and the rules of teamship.
Talking to Sir Clive Woodward part 1
Sir Clive Woodward, Former England Rugby Coach, discusses the concept of ‘Lombardi Time’ and how winning teams should embrace it.
Talking to Florent Edouard
Florent Edouard, Senior Vice President, Global Head of Commercial Excellence, Grünenthal Group, talks about AI in digital transformation.
Talking to Emily Pegg
Dr Emily Pegg, Head of Medical Affairs UK, Takeda Oncology, discusses how pharma’s relationship with HCPs is evolving.
Talking to Timothy White
Timothy White, Vice President and Head of Global Digital Commercial, Teva Pharmaceuticals, discusses the subject of digital transformation.
Talking to Paul Simms
Paul Simms, Chief Executive, Impatient Health, discusses the importance of overcoming red tape in pursuit of innovation.
Talking to Rob Jekielek
Rob Jekielek, Managing Director, The Harris Poll, discusses the evolving public perceptions of the pharma industry.
Talking to José Maria Guido Avila
José Maria Guido Avila, Global Lead HCP Marketing, Sanofi, shares his thoughts on appropriate metrics measure the success of virtual events.
Talking to Ipsen's UK & Ireland team
Four Ipsen colleagues discuss the fabric and value of high-performing teams, especially against the backdrop of COVID-19.
Talking to Uzair Qadeer
Uzair Qadeer, Chief Diversity Officer, Alexion, discusses his notable career as an HR futurist, plus diversity and belonging in pharma.
Talking to Kevin O'Brien
Kevin O’Brien, President, North America, Merz Therapeutics, talks about the intricacies of developing a treatment for a new indication.
Talking to Ester Banque
Ester Banque, Senior Vice President and Head of Intercontinental Commercial, BMS, talks about her unique approach to leadership.
Talking to Kay Wesley
Kay Wesley, Chief Executive, Kanga Health, talks about pharma’s digital transformation and her passion for creating gender equality.
Talking to Nancy Globus
Nancy Globus, Vice President for Regulatory and Medicine Safety, Addison Whitney, talks medication safety, product labelling and errors.
The 2021 pharma forecast
Looking forward to the year ahead, GOLD casts five predictions for what the standout advancements and priorities will be for pharma in 2021.
Talking to Karen Moyse
Karen Moyse, Founder and Managing Director, KineticFuture Leadership, discusses best practices for managing conflicting personalities.
Talking to Isma Benattia
Isma Benattia, Vice President Europe Medical Affairs, Amgen talks about harnessing technology to unlock better outcomes for patients.
Talking to Arun Mahtani
Arun Mahtani, Former Vice President, Channels Strategy and Digital Content, Teva Pharmaceuticals, talks about impactful patient initiatives.
Talking to Kumaran Krishnan
Kumaran Krishnan, Director, Medical Excellence and Digital Transformation, Teva, discusses unlocking further potential in developed markets.
Talking to Pierre Bourdage
Pierre Bourdage, Global Head Biopharmaceuticals, Sandoz, provides insight into the state and future of the biosimilars market.
Talking to Patrick Romano
Patrick Romano, Co-founder and Partner, Eradigm Consulting, talks about his experience as a biochemist, how to build pharmaceutical value propositions fit for the future, and how the industry can navigate the blurring of lines between pharma and public health.
Talking to Ian Dorrian
Ian Dorrian, President Communications Europe, Syneos Health, talks about his journey from the pharmaceutical industry to the agency world, what pharma can do to mitigate the spread of fake news, and how long-term use of virtual communication could affect product launches of the future.
Talking to Haider Alleg
Haider Alleg, Global Head of Digital Excellence, Ferring Pharmaceuticals, reveals his fascination with Japanese business methodologies and considers what both the pharmaceutical and financial sectors could stand to learn from one another.
Talking to Fran Ayalasomayajula
Fran Ayalasomayajula, Head of Population Health Portfolio, Worldwide Healthcare, HP, discusses scaling technological adoption, thought leadership, and the positive impact technology will have on future population health.
Talking to Denice Torres
Denice Torres, ex-Chief Strategy and Business Transformation Officer, Johnson & Johnson, and Founder, The Mentoring Place and The Ignited Company, discusses the importance of diversity and having a positive mindset, why being different is your secret weapon, and how to empower people and patients alike.
Talking to Ben Hunt-Davis
Ben Hunt-Davis, Olympic rowing champion and CEO of the business performance consultancy Will It Make The Boat Go Faster?, talks about the demands of professional sport, applying Olympic training principles to business and how to use reviews to generate personal growth.
Talking to Sir Martin Sorrell
Legendary businessman Sir Martin Sorrell talks to GOLD about the importance of making decisions without delays, the power of being the best to become the biggest, and having a roadmap to lead you to your goals.
Talking to Nina Antinora
Nina Antinora, CEO of mindfulness company Change It Up, talks about the importance of soft skills for both marketing and medical affairs professionals, how to prevent burnout, and incorporating mindfulness into your daily schedule.
Talking to Dario Safaric
Dario Safaric, Chairman of the NEXT Pharma Summit, shares his journey of starting a conference from scratch, Croatia’s historical relationship with the pharmaceutical industry, and the future outlook for medical conferences in the post-COVID-19 era.
Talking to Nigel Adkins
Nigel Adkins, professional football manager, former player, and physiotherapist, talks about his career in football, the valuable lessons he has learnt about leadership, and the importance of routine in navigating challenging professional periods.
Talking to Dr John Michels
Dr John Michels, former NFL player turned renowned interventional pain specialist, explores the mindset it takes to become successful, how to be the master of your own outcomes and the science behind negative habit cycles and how to beat them.
Talking to Steve Ingham
Steve Ingham, leading performance scientist and founder of the performance consultancy, Supporting Champions, talks about his work with the British Olympic team, how to earn the respect of high performers, and what businesses can learn from the mindsets of professional athletes.
Talking to Mircea Cubillos
Mircea Cubillos, Vice President Hematology EMEA, Commercial Strategy Lead, Janssen, discusses his lengthy career at Janssen, progression in oncology during COVID-19, and cultivating healthy habits during lockdown.
Talking to Will Champion
Will Champion, drummer for the band Coldplay, discusses the mindset it takes to become and remain successful, as well as how to cultivate effective collaboration and sustain passion and creativity over long stretches of time.
Talking to Dr Gino Martini
Dr Gino Martini, Chief Scientist, Royal Pharmaceutical Society, covers the rapid data generation of COVID-19, the value of digital for HCPs, and why he thinks there will be much to reflect on after the pandemic has passed.
Talking to Olli Rundgren
Olli Rundgren, CEO, Psyon Games, chats about the power of games and how they can positively impact health and behaviour. Olli discusses the formation of habits, the opportunity for education and data collection, and Psyon Games’ WHO endorsed game ‘Antidote’.
Talking to Sarah Rickwood
Sarah Rickwood, Vice President of Thought Leadership and Marketing, IQVIA, talks about the key trends and challenges that have shaped the past decade in pharma, RWE, multi-channel marketing and the future of drug launch post-COVID-19.
Talking to Grant Cardone
Grant Cardone, renowned sales expert, motivational speaker, author, and property tycoon, shares his approach to maintaining a positive mindset, considers the future of entrepreneurship, and offers advice on how to advance your business in a crisis.
Loading posts...
« Previous
1
…
20
21
22
23
24
25
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View